Scripsamerica (OTCMKTS:SCRCQ - Get Free Report) and West Pharmaceutical Services (NYSE: WST - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Profitability This table compares Scripsamerica and West Pharmaceutical

Shares of West Pharmaceutical Services, Inc. (NYSE: WST - Get Free Report) have been given a consensus rating of "Moderate Buy" by the fourteen brokerages that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a

Caxton Associates LLP bought a new position in shares of West Pharmaceutical Services, Inc. (NYSE: WST) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 7,360 shares of the medical instruments supplier's stock, valued at approximately $1,610,000. Several

Headlands Technologies LLC boosted its holdings in West Pharmaceutical Services, Inc. (NYSE: WST) by 326.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,789 shares of the medical instruments supplier's stock after acquiring an additional 6,728 shares during the quarter. Headlands

Bamco Inc. NY cut its position in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 26.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 307,647 shares of the medical instruments supplier's stock after selling 108,501 shares during the

EXTON, Pa. , Dec. 12, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 9:00 am PST in San Francisco, California.

California Public Employees Retirement System increased its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 5.1% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 94,256 shares of the medical instruments supplier's stock after acquiring an additional 4,562 shares during the period.

WST leans on strong HVP demand, rising GLP-1 exposure and Annex 1 tailwinds, even as pricing and device margins weigh on near-term performance.

EXTON, Pa. , Dec. 10, 2025 /PRNewswire/ -- On December 9, 2025, the board of directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on February 4, 2026, to shareholders of record on January 28, 2026.

I track a custom universe of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities based on valuation and forward return potential. 28 of these stocks currently offer estimated future returns of at least 10%, with 18 appearing potentially undervalued per my Free Cash Flow model. Top-ranked names like ResMed, Mastercard, and MSCI combine strong projected EPS growth with reasonable valuations.